Literature DB >> 28534416

Comparison of statistical methods for detection of serum lipid biomarkers for mesothelioma and asbestos exposure.

Rengyi Xu1,2, Clementina Mesaros1, Liwei Weng1, Nathaniel W Snyder3, Anil Vachani1,4, Ian A Blair1, Wei-Ting Hwang1,2.   

Abstract

AIM: We compared three statistical methods in selecting a panel of serum lipid biomarkers for mesothelioma and asbestos exposure. MATERIALS &
METHODS: Serum samples from mesothelioma, asbestos-exposed subjects and controls (40 per group) were analyzed. Three variable selection methods were considered: top-ranked predictors from univariate model, stepwise and least absolute shrinkage and selection operator. Crossed-validated area under the receiver operating characteristic curve was used to compare the prediction performance.
RESULTS: Lipids with high crossed-validated area under the curve were identified. Lipid with mass-to-charge ratio of 372.31 was selected by all three methods comparing mesothelioma versus control. Lipids with mass-to-charge ratio of 1464.80 and 329.21 were selected by two models for asbestos exposure versus control.
CONCLUSION: Different methods selected a similar set of serum lipids. Combining candidate biomarkers can improve prediction.

Entities:  

Keywords:  LASSO; PCA; asbestos exposure; biomarker; mesothelioma; stepwise regression

Mesh:

Substances:

Year:  2017        PMID: 28534416      PMCID: PMC5619144          DOI: 10.2217/bmm-2017-0087

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  16 in total

Review 1.  Environmental exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis.

Authors:  V Bourdès; P Boffetta; P Pisani
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

2.  Serum biomarkers in patients with mesothelioma and pleural plaques and healthy subjects exposed to naturally occurring asbestos.

Authors:  Mehmet Bayram; Isa Dongel; Ali Akbaş; Ismail Benli; Muhammed Emin Akkoyunlu; Nur Dilek Bakan
Journal:  Lung       Date:  2013-10-30       Impact factor: 2.584

3.  Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma.

Authors:  A Lacourt; C Gramond; P Rolland; S Ducamp; S Audignon; P Astoul; S Chamming's; A Gilg Soit Ilg; M Rinaldo; C Raherison; F Galateau-Salle; E Imbernon; J C Pairon; M Goldberg; P Brochard
Journal:  Thorax       Date:  2014-02-07       Impact factor: 9.139

4.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

5.  Asbestos exposure, pleural mesothelioma, and serum osteopontin levels.

Authors:  Harvey I Pass; Dan Lott; Fulvio Lonardo; Michael Harbut; Zhandong Liu; Naimei Tang; Michele Carbone; Craig Webb; Anil Wali
Journal:  N Engl J Med       Date:  2005-10-13       Impact factor: 91.245

6.  Mesothelin-family proteins and diagnosis of mesothelioma.

Authors:  Bruce W S Robinson; Jenette Creaney; Richard Lake; Anna Nowak; A William Musk; Nick de Klerk; Pernilla Winzell; Karl Erik Hellstrom; Ingegerd Hellstrom
Journal:  Lancet       Date:  2003-11-15       Impact factor: 79.321

7.  Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma.

Authors:  C Boutin; E Nussbaum; I Monnet; J Bignon; R Vanderschueren; J C Guerin; O Menard; P Mignot; G Dabouis; J Y Douillard
Journal:  Cancer       Date:  1994-11-01       Impact factor: 6.860

8.  Pleural mesothelioma and occupational and non-occupational asbestos exposure: a case-control study with quantitative risk assessment.

Authors:  Daniela Ferrante; Dario Mirabelli; Sara Tunesi; Benedetto Terracini; Corrado Magnani
Journal:  Occup Environ Med       Date:  2015-08-11       Impact factor: 4.402

9.  HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.

Authors:  Andrea Napolitano; Daniel J Antoine; Laura Pellegrini; Francine Baumann; Ian Pagano; Sandra Pastorino; Chandra M Goparaju; Kirill Prokrym; Claudia Canino; Harvey I Pass; Michele Carbone; Haining Yang
Journal:  Clin Cancer Res       Date:  2016-01-05       Impact factor: 12.531

10.  Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis.

Authors:  Michaela B Kirschner; Emily Pulford; Mir Alireza Hoda; Anita Rozsas; Kim Griggs; Yuen Yee Cheng; J James B Edelman; Steven C Kao; Rebecca Hyland; Yawen Dong; Viktoria László; Thomas Klikovits; Michael P Vallely; Michael Grusch; Balazs Hegedus; Balazs Dome; Walter Klepetko; Nico van Zandwijk; Sonja Klebe; Glen Reid
Journal:  Br J Cancer       Date:  2015-08-11       Impact factor: 7.640

View more
  1 in total

1.  Understanding exposures and latent disease risk within the National Institute of Environmental Health Sciences Superfund Research Program.

Authors:  Sara M Amolegbe; Danielle J Carlin; Heather F Henry; Michelle L Heacock; Brittany A Trottier; William A Suk
Journal:  Exp Biol Med (Maywood)       Date:  2022-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.